Diagnexia has been shortlisted for Health Tech Product of the Year at the LaingBuisson Awards 2026
recent articles
Originally published on KevinMD.com by Dr. Michael Misialek, a practicing pathologist in Massachusetts. As a pathologist, I recognize the importance of every diagnosis. Behind each slide is a patient, a family, a network of family and...
Visit Definiens at booth #423 at the Molecular Med-Tri-Con conference, February 16-18 to learn about Definiens’ comprehensive range of digital and molecular pathology solutions for imaging and quantifying biomarkers in tissue sections. At...
PathXL has today launched a next generation tablet version for PathXL Tutor that delivers a broad range of new capabilities to the marketplace. This new product was developed in a close working partnership with the University of...
Thanks to everyone who participated in our recent draw for a 6 month license of microDimensions Voloom! The winner of a free license for Voloom, the fastest and most versatile software for histology 3D reconstruction, has been drawn. Among all...
Date: Thursday, January 29th Time: 10am - 11am CST | 4pm - 5pm GMT Prof. Peter Hamilton | VP Research and Development, PathXL Eileen Regan | Head of Account Management and Pre-Sales Empower your...
Applied Spectral Imaging receives FDA Clearance for GenASIs™ HiPath...
- Anatomic Pathology
- Business
- Clinical Laboratories
- Device Manufacturers
- Digital Pathology News
- Genetics
- Government
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Management & Operations
- Marketing
- Microscopy
- Pathology News
- Standards and Guidelines
- Vendor products
- Web/Tech
Carlsbad, CA. - January 21, 2015 - Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its GenASIs HiPath image capture and analysis...
































